Ou Chih-Ying, Chen Chiung-Zuei, Yu Chun-Hsiang, Shiu Chih-Hui, Hsiue Tzuen-Ren
Division of Chest Medicine, Department of Internal Medicine, National Cheng Kung University Hospital, Tainan, Taiwan.
Respirology. 2014 Jul;19(5):694-9. doi: 10.1111/resp.12313. Epub 2014 May 6.
Chronic obstructive pulmonary disease (COPD) is a pulmonary disease with systemic involvement. Several multidimensional indices have been developed to predict long-term outcomes. However, these indices have not been compared and validated in Taiwanese patients with COPD.
A prospective, observational, hospital-based study was designed, and a total of 621 patients were recruited from May 2006 to December 2011. Patients followed at least 1 year were enrolled and 594 patients eligible for inclusion. Three prognostic indices--the ADO (age, dyspnoea and airflow obstruction), BODEx (body mass index, airflow obstruction, dyspnoea and exacerbations), and CPI (the COPD Prognostic Index)--were validated and the predictive power of each was analysed.
The median follow-up of the 594 patients was 33 months (range 1-72 months), and the mortality rate was 19.2% (114 deaths). All indices were significantly predictive for all-cause mortality in our validation cohort. Furthermore, the C statistics of the three indices, indicating their predictive accuracy, were all >0.7 (area under the curve of the CPI 0.718, P < 0.001, ADO 0.702, P < 0.001, BODEx 0.702, P < 0.001).
ADO, BODEx and CPI scores are useful predictors of all-cause mortality with significantly discriminative properties in Taiwanese patients with COPD.
慢性阻塞性肺疾病(COPD)是一种累及全身的肺部疾病。已开发出多种多维指标来预测长期预后。然而,这些指标尚未在台湾COPD患者中进行比较和验证。
设计了一项基于医院的前瞻性观察性研究,于2006年5月至2011年12月共招募了621例患者。纳入至少随访1年的患者,594例符合纳入标准。对三个预后指标——ADO(年龄、呼吸困难和气流受限)、BODEx(体重指数、气流受限、呼吸困难和急性加重)和CPI(COPD预后指数)进行验证,并分析每个指标的预测能力。
594例患者的中位随访时间为33个月(范围1 - 72个月),死亡率为19.2%(114例死亡)。在我们的验证队列中,所有指标对全因死亡率均有显著预测作用。此外,这三个指标的C统计量(表明其预测准确性)均>0.7(CPI的曲线下面积为0.718,P < 0.001;ADO为0.702,P < 0.001;BODEx为0.702,P < 0.001)。
在台湾COPD患者中,ADO、BODEx和CPI评分是全因死亡率的有用预测指标,具有显著的鉴别特性。